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Summary.
Accumulating evidence supports the contention that CD4 and CD8 receptor molecules play a
critical signaling role during thymocyte development. The lymphocyte-specific protein tyrosine
kinase (p56kk), by virtue of its physical association with these surface components, provides a
likely candidate for the biochemical signal transducing element required for these effects. To
investigate the function of p56kk in T lymphocytes, transgenic mice were produced that carry
either the wild-type lck gene or a mutated lck gene encoding a constitutively activated form
of p56kk (p56kkFSOS). Both transgenes were expressed in thymocytes under the control of the lck
proximal promoter element. A large set of founder animals was obtained in which steady-state
accumulation of kk transgene mRNA directly correlated with transgene copy number, suggesting
that this transgene contains a dominant control region. Progeny of these founders exhibited a
transgene-dependent dose-related decrease in the production of thymocytes bearing functional
antigen receptors. This effect was strictly dependent on p56kk activity, in that both wild-type
and mutated versions of the genes induced similar effects with differing efficiencies. Remarkably,
even a twofold increase in p56kk abundance was sufficient to substantially disrupt the appearance
of functional thymocytes. These results indicate that thymocyte maturation is regulated in part
by signals derived from p56".
P
roduction ofmature T lymphocytes requires the prolifer-
ation of immature thymic precursors, selection of cells
bearing particular specificities of the clonotypic heterodimeric
antigen receptor (TCR), and subsequent export offunction-
ally mature cells from the thymus to peripheral lymphoid
organs (1). Signals generated through the TCR complex
influence the survival of T cell progenitors in the thymus
(2), and the activation state of mature peripheral T lympho-
cytes (3). The TCR is composed in most cases of ot and a
chains in physical association with five additional transmem-
brane proteins: the -y, S, and e proteins ofthe CD3 complex,
and the 71 and (',chains (4-6). It is widelybelieved, by analogy
with other receptor systems, that the signaling pathway from
the TCR involves activation of a phoshoinositide (PI)t-
specific phospholipase C, leading to production of diacyl-
glycerol and inositol trisphophate, which in turn provoke ac-
tivation of protein kinase C and the release of Ca2+ from
intracellular stores, respectively (7). In support ofthis model,
'Abbreviations used in this paper.hGH, human growth hormonegene; PI,
phosphoinositide.
resting T lymphocytes can in general be fully activated to
lymphokine secretion by treatment with a combination of
calcium ionophore (e.g., ionomycin) and phorbol esters (e.g.,
PMA; reference 8).
Nevertheless, recent studies indicate that lymphokine gene
expression can in some cases be achieved in the absence of
PI hydrolysis or protein kinase C activation (9, 10). Such
reports have encourageda search for additional signaling mech-
anisms that might couple the TCR/CD3 complex to meta-
bolic changes within the cell. Of particular interest has been
the observation that engagement of the TCR/CD3 complex
produces rapid changes in cellular protein phosphorylation
(11). For example, both antigen and mitogen stimulation of
T cell lines provoke tyrosine phosphorylation of the CD3
~ chain (11, 12), and even more rapid tyrosine phosphoryla-
tion of other substrates (13, 14). Tyrosine phosphorylation
of CD3 ~ has also been documented in immature thymo-
cytes undergoing selective processes in the thymus (15). Since
protein tyrosine kinases are implicated in the control of cell
growth (16), these findings suggest that the TCR/CD3 com-
plex may directly regulate the activity of a protein tyrosine
kinase during T cell activation.
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ating tyrosine phosphorylation after lymphocyte stimulation,
the product of the Ick gene is particularly attractive.A member
of them gene family, the Ick gene encodes a lymphocyte-
specific membrane-associated protein tyrosine kinase (p56kk)
that was originally identified by virtue of its overexpression
in a murine lymphoma cell line (17, 18) . Recent studies have
shown that p56kk is physically associated with both CD4
and CD8 molecules that assist in antigen recognition by T
cells (19-23) . An increasingly persuasive data set favors the
view that some fraction ofCD4 orCD8 molecules (and pre-
sumably their associated p561,k) interacts with the TCR-
CD3 complex during antigenic stimulation (24, 25) . In ad-
dition, antibody-mediated crosslinking ofCD4can in some
cases be shown to directly activate p56kk and to augment
phosphorylation of the CD3 ~ chain (26) . These observa-
tions have led to the suggestion that the CD4 andCD8poly-
peptides function by positioning p56kk within the antigen
recognition complex such that its catalytic activity can be
modulated by receptor occupancy (27) .
To investigate the role of p56kk in T cell signaling, we
have generated transgenic animals in which p56kk levels were
systematically augmented. Previous studies have shown that
the activity of p56" is itself regulated by phosphorylation
of aCOOH-terminal tyrosine residue (Tyr505), and that sub-
stitution of phenylalanine for tyrosine at this position increases
its ability to catalyze the accumulation of cellular proteins
containing phosphotyrosine (28, 29) . With this information
in mind, Ick genomic constructs were used to direct the ex-
pression of wild-type p56kk and p56kkF5o 5 in transgenic mice.
Here we report that animals expressing the 1417505 trans-
gene, or high levels of the wild-type 1ckY505 transgene, ex-
hibit disturbances in thymopoiesis. The nature of these al-
terations suggests that the level of endogenous p56kk is a
critical factor in regulating thymocyte development .
Materials and Methods
Transgene Construction .
￿
The 3' coding region of the kk gene
was reconstructed using anXmnI fragment of the 1ckF505cDNA
in the pNUT vector (30) that contained 625 by of the human
growth hormone gene (hGH) 3' untranslated region sequence en-
coding a consensus polyadenylation site. This fragment was ligated
to a 1.8-kb HindII1 fragment containing exons 9-11 of the murine
kk gene, and the remainder of the gene was reconstructed using
previously described genomic clones (31) .
Production of Transgenic Mice. Isolated Fz zygotes of C57BL6/J
x DBA/2 mice were injected with a solution of 2 ng/Wl purified
linearDNA in TE buffer (10 mM Tris, pH 7.5, 0 .1mM EDTA) .
After 24 h, viable embryos were transferred into the oviducts of
recipient pseudo-pregnant females.
Preparation and Quantitation ofTransgenic GenomicDNA.
￿
Integra-
tion of transgenic constructs into the mouse germline was assessed
by the presence of hGH sequences in mouse tail DNA . Briefly,
nucleic acids obtained after proteinase K digestion of tail explants
were extracted with phenol/chloroform and precipitated with eth-
anol. Approximately 500 ng of recovered DNA was denatured,
spotted onto nitrocellulose, baked, and hybridized with labeled
probe. The probe consisted ofsequences complementary to the 3'
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untranslated region of hGH (32) labeled with
3zP by random
priming (33) . To permit quantitation of integrated sequences, known
quantities ofthe transgene were resuspended in salmon spermDNA
and used as standards in quantitative densitometry.
Detection and Quantitation of Transgene RNA in Mouse Tissues.
RNA was recovered from homogenized tissue or single cell sus-
pensions using the guanidine-isothiocyanate method and fraction-
ated through CsCl as described (17) . RNA blotting experiments
were performed as previously described (17) . Quantitation of trans-
gene mRNA was performed both by solution hybridization (34)
using an hGH-specific oligonucleotide probe that was labeled with
3zP (30), and by densitometric analysis ofRNA slot blots after hy-
bridization using the hGH probe (isolated and labeled as above) .
Quantities of RNA loaded for densitometry were verified by hy-
bridization of probes specific for the 3' untranslated region of Ick,
or for elongation factor lot, which served as a reference standard .
TCR /3 chain transcripts were detected by hybridization with a
human CO probe (35) .
Antibody Staining and Flow Cytometric Analysis.
￿
Single cell sus-
pensions obtained from lymphoid organs were depleted of erythro-
cytes using ammonium chloride lysis (36) . Leukocytes recovered
were stained for surface expression of CD4, CD8, and CD3 sur-
face molecules, as previously described (37), using biotinylated GK1.5
(38), FITC-labeled 53-6.71 (Becton Dickinson & Co., Mountain
View, CA), and biotinylated 500AA2 (39), respectively. Detection
ofbiotinylated antibodies was facilitated using PE-conjugated strep-
tavidin (Caltag Labs, San Francisco, CA) as a second step reagent .
Multiparameter flow cytometric analysis was carried out on
FACSCAN®, or FACSTAR®, and FACSTARPLUS® cell sorters
(Becton Dickinson & Co.) . Each analysis included 10,000 events
collected in list mode files and analyzed using FACSTAR® Con-
sort 30 software.
Immunoblotting .
￿
Whole cell lysates of thymocytes were boiled
in SDS-PAGE loading buffer and analyzed by 12% SDS-PAGE anal-
ysis . After electrophoresis, proteins were transferred to nitrocellu-
lose, blotted, and developed as described (17) using rabbit an-
tiphosphotyrosine antiserum (the kind gift of Dr. Chris Wilson,
University of Washington, Seattle, WA) as the primary reagent .
Results
Transgenic Constructs.
￿
Transcription of the murine 1k gene
is regulated by two widely separated promoter elements (31,
40, 41) . The proximal (or downstream) promoter element
is active during all stages ofthymocyte development (42; our
unpublished data), and sequences including this element have
been used to direct expression of heterologous genes in the
thymocytes of transgenic mice (37, 43) . To augment p56kk
levels in thymocytes in vivo, we assembled the constructs
shown in Fig . 1 A . The pLGY and pLGF transgenes shown
in Fig. 1 A consist primarily of1k genomic sequences, be-
ginning 1.0 kb 5' of the Ick transcription start site through
the coding region ofthe murine Ickgene up to and including
exon 11 . The remainder of the Ick coding sequence is con-
tributed by murine kk cDNA sequences containing either
tyrosine (Y505) or phenylalanine (17505) codons at position
505 (28) . The transgene transcript is terminated at a single
polyadenylation site provided by the 3' untranslated region
segment of the hGH gene (32) . The presence of hGH se-
quences in the transgene constructs permits unambiguousFigure 1 .
￿
Diagrammatic representation of the pLGF and pLGY transgene constructs and in vivo expression pattern. (A) pLGF and pLGY constructs
contain 11 .2 kb of murine genomic kk sequence, including 1 .0 kb 5' to the proximal transcription start site (31) and exons 1-12 of the kk structural
gene. A portion of exon 12 sequence was obtained from the murine kk cDNA encoding either the wild-type gene with tyrosine at position 505 in
the pLGY construct, or a point mutation replacing phenylalanine for tyrosine at 505 in pLGF. The polyadenylation signal for these constructs is provided
by 625 by of3' sequence from thehGH gene. (B) 10 p,g of totalRNA recovered from indicated tissues of pLGF transgenic animal no. 671 was subjected
to electrophoresis through formaldehyde-containing agarose, blotted, and hybridized with a probe specific for 3' hGH sequences. Migration positions
of eukaryotic ribosomal RNAs are indicated to the right of the figure.
detection of transgene integration in tailDNA and trans-
gene expression in cellular RNA .
A total of 14 independent pLGF founders and 10 pLGY
founders were obtained by microinjection of (C57BL/6 x
DBA/2)F2 embryos . The characteristics of these animals
(and progeny obtained by crossing these animals with
C57BL/6J mice) are described below.
pLGF Expression Correlates with Transgene Copy Number.
C
0
p
Y
N
u
m
b
e
r
70
60
50
40
30
20
10
0
Loss of CD3
Tumor Formation
0 10Ick 20 30 40
Transgene Expression (pg/pg)
1423
￿
Abraham et al .
Transgene-encoded transcripts accumulate to high levels only
in the thymocytes ofpLGF mice (Fig. 1 B) . Not surprisingly,
independentpLGF founders differed dramatically with respect
to their expression levels of transgene-derived mRNA . Fig.
2 demonstrates that these differences in transgene expression
correlate reasonably well with the number of pLGF trans-
gene copies integrated . The level ofendogenous Ick mRNA
in thymocytes is -12 pg/Ag total mRNA (8) . Thus, our
2049
L
Figure 2 .
￿
pLGF transgene expression is correlated with
copy number and thymic phenotype . TransgenemRNA
levels were determined either by solution hybridization
assays or by quantitative densitometry. The number of
transgene copies integrated into tailDNA was similarly
assessed byquantitative densitometry using isolated trans-
gene sequences as standards. Lines above the figure indi-
cate the characteristic phenotypes observed over each dose
50
￿
interval . The level ofendogenous kkmRNA is indicated
at the bottom of the figure.transgene expression levels, which range from 1.4 pg trans-
gene mRNA/N.g total RNA in the lowest expressing founder
line (701; two to three transgene copies) to as high as 33.8
pg transgenemRNA/Ag totalRNA in the35 copy-containing
1127 founder line (Fig. 3), result in an incremental increase
in kk mRNA abundance in these lines of between 10 and
300% . Historically, in most transgenic animals generated using
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Figure 3.
￿
Representation of CD3+
cells is dependent on the quantity of
pLGF transgene expressed . (A) Thymo-
cytes from pLGF transgenics and
matched littermate controls were ana-
lyzed by quantitative flow cytometry for
the percentage of cells expressing CD3.
Values are expressed as the number of
CD3' cells in the thymus of trans-
genics as a percentage of the number
of CD3+ cells in the littermate con-
trol . (B) A similar analysis on periph-
eral lymph node of independent pLGF
founders . For both panels, animals are
arranged in order of expression level
from lowest (701) to highest (1127) .
a variety of transcriptional regulatory elements, expression
levels vary idiosyncratically and do not correlate with trans-
gene copy number (44) . The pLGF transgene may therefore
contain a thymocyte-specific dominant control region, anal-
ogous to those described in the ß-globin and CD2 loci (45,
46) . From a practical standpoint, this feature ofproximal lck
promoter activity proved useful : the phenotype of pLGFA Thymus
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animals could be reliably predicted by simple assessment of
transgene representation in tail DNA (see below) .
Dose-related Variation in the Surface Phenotypes ofpWF and
pLGY Animals.
￿
All transgenic animals expressing pLGF
mRNA exhibit disturbances in thymocyte maturation. In a
previous report (47), we described the development ofthymic
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Maturational abnormalities
in the thymic and peripheral lymphoid
cell compartments ofpLGF mice. Fluor-
escence staining profiles ofsurface CD3,
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tumors in those mice that express high levels of the pLGF
and pLGY transgenes . Although this effect is dramatic, the
predominant consequence of increased p56kk expression in
developing thymocytes is delayed or arrested maturation. This
maturational arrest does not dramatically affect thymus cel-
lularity, as the average number of thymocytes recovered from
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￿
Correlation between extent of maturational disturbance and levels of lck transgene expression in thymocytes from pLGF mice. Thymocytes
recovered from indicated animals at 8 wk of age were analyzed by dual parameter flow cytometry for the expression ofCD8 (x-axis) and CD4 (Y
axis), as previously shown . CD4 to CD8 ratios of single-positive thymocytes are indicated in the lower right quadrant in each panel . Animals are
arranged in order of expression level from lowest (2957 to highest (1127) .
individuals of each pLGF and pLGY line at ti4 wk of age
are similar to age-matched littermate controls (2.0 x 108 in
the transgenics as compared with 1.7 x 108 for controls) .
However, many fewer of these Thy-1+ Tymocytes are
CD3 + when compared with littermate controls . Analysis of
12 independent pLGF lines revealed that the ability to pro-
duce CD3 + Tymocytes correlated inversely with pLGF ex-
pression level. Thus, as steady-state levels ofpLGF transcripts
increase, the representation of CD3+ mature Tymocytes
declines (Table 1 and Fig . 3 A) .
Transgenic animals that express pLGF at double to triple
endogenous levels (-20-30pg/jg total RNA ; including the
2943, 2949, and 1127 lines) manifest the most severe pheno-
typic disturbances . Fig. 4 A documents typical findings in
the thymus of a 3.5-wk-old animal representative of this group
(1127 line) . Although >98% of the Tymocytes in these
animals are Thy-1+ (data not shown), CD3+ cells are vir-
tually absent . This striking decrease in thymic CD3 expres-
sion is accompanied by a dramatic alteration in CD4 andCD8
Figure 6 .
￿
Reduced levels offull-lengthTCR 0 chain transcripts in pLGF
thymocytes. 10,ug of totalRNA recovered from thymocytes ofindicated
animals was analyzed by northern blotting using a probe specific for the
constant region of the TCR 0 chain . Migration positions of eukaryotic
ribosomal RNAs are indicated at the right of the figure. Migration posi-
tions of alternate forms of 0 chain transcripts are indicated in kilobases
at the left of the figure.
1127 '
0 .018Table 1.
￿
Phenotype Associated with p56" Overexpression
Number of individual animals analyzed in each founder line .
s Transgene mRNA expression in pg/Ftg total cellular RNA.
5 Transgene integrants/genome equivalent .
0 Tumor formation by 8 wk of age .
I Total number of CD3+ cells in thymus or spleen as a percentage of normal littermate control value .
staining profiles, with relative enrichments of >20-fold in
double-negative cells (from 1.9% to 44.3%) and 10-fold in
CD4 - 8 + cells (to >30%) . Double-positive and CD4+ cells
are concomitantly reduced in number. In addition, virtually
all of the CD8+ cells that remain exhibit an immature
CD810 phenotype, expressing approximately fivefold less sur-
faceCD8 than normal thymocytes. Fig . 5 provides histograms
documenting the spectrum ofCD4 and CD8 expression ob-
served in representative pLGF animals of similar ages arranged
according to the level of transgene expression . Clearly, as lck
transgene expression increases, the relative proportion of cells
with mature CD4+8 - or CD4- 8+ phenotypes declines, and
a dramatic decrease in the CD4/CD8 ratio among such single-
positive thymocytes becomes evident .
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Another measure of the accumulation of immature cells
in the thymuses ofpLGF animals was obtained by examining
the representation of transcripts derived from the TCR (3
chain locus . Rearrangement of(3 chain gene segments occurs
relatively early in thymocyte development . Transcripts (1.0
kb) derived from DsJ3joining events are ordinarily observ-
able by day 14 of fetal life, and complete Vs-Ds-Jg-con-
taining transcripts (1.3 kb) become predominant by fetal day
18 (48) . In thymocytes from adult pLGF mice, however, the
vast majority of0-containing transcripts derive from incom-
pletely rearranged DoJo joining events (Fig . 6) . Hence, with
respect to cell surface phenotypes and TCR gene rearrange-
ments, overexpression of p56kk retards the normal develop-
mental sequence.
Phenotype Founder n"
Transgene
expressions
Copy
numbers
Tumor
formation1l
CD3
Thymus
(%C)
Periphery)
pgll4g
pLGFhi 1127 23 33.8 58.6 + 1 .0 3.0
2949 7 35.0 25.0 + 4.0 15.0
2943 1 23.4 50.0 + 9.5 13.1
671 1 ND ND ND 11.0 16.0
pLGFmid 2954 13 11.7 12.8 - 13.0 66.0
2964 5 10.0 10.3 - 12.0 42 .4
3082 7 ND ND - 10.6 51 .4
3122 1 9.0 17.4 - 33.0 83.0
3073 9 6 .0 4.0 - 36.5 84.5
629 1 ND ND ND 53.0 92 .9
pLGFlo 2961 3 ND 3 .7 62.0 85 .0
701 13 1.4 2.3 70.3 81 .6
2957 5 ND 1.2 76.5 100.0
795 6 ND 1 .7 78.8 107.2
pLGYhi 4220 12 75 .0 49.2 + 11.9 48.5
7233 5 ND 64.5 + 35.9 35 .6
pLGYmid 1610 1 11 .0 ND ND 68.6 93:1
7240 1 ND 28 .1 - 88.1 117.0
1627 1 ND ND ND 98.6 85.7
pLGYlo 1570 1 1 .5 ND ND 99 .2 99.5
7246 1 ND 12.3 - 123.9 97.6
1592 4 ND ND - 92.2 99.4
1572 3 ND ND - 101 .3 101 .7d17.5 fetus!
adult
d19 fetus
d2 neonatee
Ila ,
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Figure 7 .
￿
Developmentally delayed acquisition of surface CD4 andCD8 in transgenic thymocytes. Shown are fluorescence profiles of surfaceCD4
and CD8 molecules on thymocytes of either control, pLGY, or pLGF transgenic mice at the indicated stages of life .
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Overexpression of Ick in Transgenic MiceNot surprisingly, the accumulation of T cells in periph-
eral lymphoid organs was also impaired by expression of the
1ckF505 transgene (Table 1 ; Figs. 3Band 4 B) . Accordingly,
in most cases it was possible to rapidly assess the degree of
disruption of thymopoiesis by enumeration of CD3+ cells
in peripheral blood (data not shown) . Again, decreased
representation of mature CD3+ lymphocytes correlated in-
versely with pLGF transcript abundance.
Overexpression of the Normal lck Gene Is Not Benign .
￿
To
determine whether the alternations in thymopoiesis observed
in pLGF mice were uniquely provoked by the lckF505 mu-
tant transgene, we examined animals bearing a wild-type Ick
construct (pLGY) . Animals with transgene expression at ap-
proximately endogenous levels (e.g ., no. 1610, with 11 pg
pLGY mRNA/hg total RNA) exhibited a modest reduc-
tion in CD3-expressing thymocytes (Table 1) . The pheno-
type observed in animals expressing pLGY at this level thus
approximates that observed in pLGF mice expressing seven-
fold lower levels oftransgene transcripts, providing an in vivo
estimate for the extent of activation of p56kk induced by the
F505 mutation . Indeed, animals overexpressing the pLGY
transgene at extraordinarily high levels (at least twofold higher
than the highest expressing pLGF line) also develop thymic
tumors (Table 1, and reference 47) . Thus, augmentation of
total p56kk activity, whether by simple overexpression or by
expression ofthe kkF505 mutant, profoundly disrupts thymo-
cyte maturation .
ThymocyteMaturation inpLGF andpLGY Transgenic Animals
Proceeds with Delayed Kinetics. To examine the basis of the
Ick transgene effects, we studied thymocyte ontogeny in high-
expressing pLGF andpLGY mice . Fig. 7 illustrates theCD4
and CD8 staining profiles of pLGF and pLGY thymocytes
(1127 and 4220 lines, respectively) during early life. Both of
the Ick transgenic animals appear to generate thymocytes with
normal surface receptor expression, but do so with greatly
delayed kinetics . Thus, the CD4/CD8 expression profile of
an adult 4220 PLGY animal resembles that seen in a normal
1429
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Figure 8 . Increased phosphotyrosine levels in pLGF
transgenic thymocytes. Wholecell lysates (50,ug total pro-
tein) obtained from dispersed thymocytes of animals from
indicated pIGF transgenic lines and a control animal (Con-
trol) were analyzed by immunoblotting using a phos-
photyrosine-specific antiserum (obtained from Dr. Chris
Wilson, University of Washington) . Transgenic samples
are arranged with increasing transgene expression levels
from left to right . The migration positions ofprotein stan-
dards in kilodaltons are indicated to the left ofthe figure.
animal at 19 d of gestation . Although the appearance of
CD3+ cells in pLGY mice might represent successful matu-
ration of those few thymocytes in which transgene expres-
sion is for some reason decreased, it is remarkable that the
extent of disruption of development correlates extremely well
with the level of kk transgene expression (Table 1 and data
not shown) . This result suggests that thymocyte maturation
can only proceed successfully when Ick gene expression (or
more precisely, p56kk activity) is maintained below some
critical level . One measure of this activity would be the ac-
cumulation of substrates bearing phosphotyrosine.
Increased Phosphotyrosine Content inpLGF Thymocytes.
￿
Im-
munoblotting studies performed using phosphotyrosine-
specific antisera to examinepLGF thymocyte lysates revealed
a very large number of substrates, all presumed targets for
p56kkF505-mediated phosphorylation (Fig . 8) . The accumu-
lation of phosphotyrosine-containing phosphoproteins in
pLGF transgenic mice roughly paralleled transgene expres-
sion level (Table 1 and Fig. 2) . Hence, there was a direct corre-
lation between p56" kinase activity, phosphotyrosine ac-
cumulation, and the extent of disruption observed in
thymocyte maturation exhibited by Ick transgenic mice .
Discussion
To investigate the functional importance of p56", we have
generated transgenic animals bearing both wild-type kkY505
and mutant 1ckF505 expression constructs . This approach has
several advantages over transfection of clonedT cell lines. First,
expression was achieved in otherwise normal lymphocytes,
obviating concerns about aberrant signaling pathways that
might emerge in cells adapted to in vitro growth conditions.
Second, expression of Ick transgenes in the thymus permitted
an analysis of the effects of augmented p56" activity on
thymocyte development, a process that is not yet amenable
to in vitro dissection . Indeed, thymocyte maturation proved
exquisitely sensitive to p56kk overexpression . Analysis of thephenotypes of the pLGF and pLGY animals permits some
inferences regarding the normal function of the Ick gene and
its product during thymopoiesis .
Dominant Control ofIck Transgene Expression .
￿
By gener-
ating large numbers of founder animals, we observed that
steady-state accumulation of pLGF (and pLGY) transgene
mRNA is determined by the number of copies of the trans-
gene integrated into host DNA . This phenomenon is un-
usual (44) but has been previously observed in at least two
other gene systems : the (3-globin genes (45) and, in a less
thoroughly analyzed case, the CD2 gene (46) . Importantly,
globin constructs containing the dominant control region
are expressed at levels comparable with the endogenous gene :
a single transgene integrant, irrespective ofthe site ofintegra-
tion, yields steady-state transcript levels approximately equiva-
lent to those derived from a single endogenous element .
The pLGF transgene behaves similarly in that transcript
accumulation is copy number dependent . Hence, by this
criterion, the pLGF transgene contains a dominant control
region . However, it is difficult to compare Ick transgene ex-
pression levels with those of the endogenous Ick alleles, since
both the proximal and distal Ick gene promoters are simul-
taneously active in thymocytes (31, 42) . Although extrapo-
lations from our data suggest that 10 copies of the pLGF
transgene are required to match transcriptions of the endog-
enous gene, the real value must be considerably lower. It is
also possible that the pLGF transgene lacks additional posi-
tive regulatory elements found in the endogenous gene. In
any case, identification of the Ick dominant control region
will clearly be of considerable interest, both in terms of
elucidating the transcriptional regulation ofthe kk gene, and
as a means of obtaining more efficient expression constructs
for thymocytes and other lymphoid cells .
Augmented kk Expression Delays ThymocyteMaturation .
￿
The
primary disturbance inpLGF mice is the loss ofmature func-
tional CD3+ cells . When high levels of p56kk activity are
present, the predominant cell phenotype in the thymus is
Thy-1+ and CD3 -CD8 10 or CD3 -CD8 - . Decreased ex-
pression of the pLGF transgene permits appearance of more
normal numbers of CD3+ cells . Two lines of evidence sup-
port the contention that these disturbances are not the result
of an artifactual property of activated p56kkF 5o5 . First, in sep-
arate experiments, we have observed that overexpression of
another src family kinase, p59Jy", in transgenic animals under
the control of the kk proximal promoter element yields thymo-
cytes that exhibit a normal maturational sequence despite dis-
ruption of TCR-mediated signaling (49, 50) . In addition,
animals bearing transgenes encoding an activated form of an
unrelated tyrosine kinase, hck, also exhibit no thymic devel-
opment defects (data not shown) . Second, and more persua-
sively, pLGY transgenic thymocytes, when compared with
pLGF, show similar though less exaggerated abnormalities.
In fact, assuming that p56kkYSO5 and p56kkFSOS are equally
stable, these proteins yield identical in vivo phenotypes at
a ratio of N7:1 (Table 1) . These results strongly support the
view that p56kkP5o5 acts qualitatively in the same fashion as
its wild-type counterpart, but yields quantitatively superior
effects.
Numerous possible explanations exist for the disrupted
maturation of thymocytes inpLGF andpLGY mice . It is ap-
parent, however, that p56kk activity crucially regulates thy-
mocyte development . In fact, a simple doubling of the steady-
state level of p56kk mRNA in the pLGY transgenics impairs
the development of thymocytes with mature phenotypes (Table
1) . It is attractive to view these results in the context of the
known association of p50 with the CD4 and CD8 co-
receptor molecules. pLGF animals exhibit a transgene dose-
dependent reduction in CD4 expression and simultaneously
accumulate CD81° cells in both the thymus and the peri-
phery (Fig . 4) . This observation suggests that thymopoiesis
in pLGF animals is disrupted at the point where immature
CD3 - cells begin to acquire cell surface CD8 and CD4 (51) .
Consistent with this view, the thymocytes ofpLGF animals
contain few full-length TCR (3 chain transcripts, implying
that maturation is disrupted at or near the time when Vs
gene rearrangements occur (Fig. 6) . Excessive p56kk activity
may therefore provide a toxic or suppressive signal when cou-
pled to appropriate cell surface receptors . In this context, it
is important to note that CD8 ci chains interact considerably
less well with p56kk than do CD4 polypeptides, and that the
CD8 0 chain fails to associate with p56" entirely (23) .
Hence, if p56kk delivers a suppressive or inhibitory signal
during development in response to stimulation of CD4 and
CD8 coreceptors, CD8 expression would be expected to be
better tolerated in pLGF thymocytes . Regardless of the pre-
cise mechanism involved, it is clear that the level of activity
of the kk-encoded protein tyrosine kinase must be strictly
controlled in order for thymocyte development to proceed .
Since even modest increases in p56U abundance result in
significant developmental disturbances, it is possible that al-
ternations in Ick expression or in p56kk structure may un-
derlie some human immunodeficiency diseases .
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